1 Wertli M, Nuschin Djalali S, Kherad O, Schneemann M, Rampini S, Rohrbasser A et al. Qualitätsindikatoren im stationären Bereich. Schweiz Ärzteztg. 2021;102(26):877-880
https://saez.ch/article/doi/saez.2021.202892 stationär - SGAIM - SSMIG – SSGIM.
https://www.sgaim.ch/de/qualitaet/qualitaet-im-spital/qualitaetsindikatoren3 Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry. 2015 Feb;72(2):136-42. 4 Landolt S, Rosemann T, Blozik E, Brüngger B, Huber CA. Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes. Neuropsychiatr Dis Treat. 2021;17:1021-10345 Benzodiazepine / Schweizer Versorgungsatlas6
www.smartermedicine.ch/de/top-5-listen/stationaere-allgemeine-innere-medizin 7 Udayakumar P , Beck T , Koch J , Wertli M , Baumgartner C. Hemoglobin thresholds for transfusion: how are we doing in the era of Choosing Wisely? Primary and Hospital Care 2021;21 (Suppl. 11): 39-40
8 Jeganathan-Udayakumar P, Tochtermann N, Beck T, Wertli MM, Baumgartner C. Hemoglobin thresholds for transfusion: how are we doing in the era of Choosing Wisely? A retrospective cohort study. Swiss Med Wkly. 2023;153:40132.9 Jäger C, Mohr G, Gökcimen K, Navarini A, Schwendimann R, Müller S. Critical incident reporting over time: a retrospective, descriptive analysis of 5493 cases. Swiss Med Wkly. 2021;151:w3009810 Impfempfehlungen für Beschäftigte im Gesundheitswesen. Bull BAG 2009; Nr. 43: 804–8